AMNEAL PHARMACEUTICALS, INC. Other Non-Current Assets
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Other Non-Current Assets of $80.67 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $80.67M.
- 2026-03-31: Other Assets, Noncurrent $54.88M.
- 2025-12-31: Other Assets, Noncurrent $57.80M.
- 2025-09-30: Other Assets, Noncurrent $39.46M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $80.67M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $54.88M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $57.80M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $39.46M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $44.85M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $45.42M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $60.13M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $36.27M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $77.03M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $73.75M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $55.52M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $89.04M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $93.24M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $86.43M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $103.22M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $108.26M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $79.84M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $63.94M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $20.61M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $19.53M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $19.22M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $19.56M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $22.34M 10-K · filed 2022-03-01 | $31.89M 10-K · filed 2021-03-01 |
| 2020-09-30 | $31.14M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $28.73M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $26.46M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $44.27M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $18.61M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $63.46M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $62.42M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $67.59M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $73.64M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $78.65M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $11.26M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |